Navigation Links
AxoGen, Inc. to Highlight Products at the American Academy of Orthopedic Surgeons 2013 Meeting

Alachua, FL (PRWEB) March 18, 2013

AxoGen, Inc. (OTCBB: AXGN), a leading regenerative medicine company focused on the commercialization of proprietary products and technologies for peripheral nerve reconstruction and regeneration, announced today that it will be highlighting its products at the American Academy of Orthopedic Surgeons (AAOS) 2013 Annual Meeting, March 19-22, 2013 at McCormick Place in Chicago. The AxoGen booth (#4750) will be featured in the First-Time Exhibitor section where attendees can view new and exciting technologies in orthopedic surgery.

Jill Schiaparelli, Senior Vice President, Business Strategy & Marketing, said, “AxoGen is excited to be presenting at the AAOS 2013 Annual Meeting for the first time. There has been increasing demand for our products by orthopedic surgeons who repair injured peripheral nerves.     The AAOS 2013 meeting is the largest orthopedic meeting in the world and an excellent opportunity to highlight our nerve repair technologies with this important market segment. Our booth will feature our full suite of products: Avance® Nerve Graft, AxoGuard® Nerve Connector and AxoGuard® Nerve Protector.”

The AAOS has more than 36,000 members worldwide. The Annual Meeting is the largest orthopedic meeting in the world, featuring presentations of scientific papers, scientific poster and technical exhibits, instructional courses, educational symposia, and company exhibits.

About AxoGen, Inc.
AxoGen (AXGN) is a regenerative medicine company dedicated to advancing the science and commercialization of peripheral nerve repair solutions. The Company’s innovative approach to regenerative medicine has resulted in first-in-class products that will define their product categories. AxoGen’s products offer a full suite of surgical nerve reconstruction solutions including Avance® Nerve Graft, the only commercially available processed nerve allograft for bridging severed nerves without the comorbidities associated with a second surgical site, AxoGuard® Nerve Connector, a porcine submucosa ECM coaptation aid for tensionless repair of severed nerves, and AxoGuard® Nerve Protector, a porcine submucosa ECM product used to wrap and protect injured peripheral nerves and reinforce coaptation sites while preventing soft tissue attachments. For more information, visit our website at

AxoGen is the parent of its wholly owned operating subsidiary, AxoGen Corporation. AxoGen’s principal executive office and operations are located in Alachua, FL. To receive email alerts directly from AxoGen, please click here

Read the full story at

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. AxoGen, Inc. Appoints Shawn McCarrey as Vice President of Sales
2. AxoGen, Inc. Announces Presentation of Avance® Nerve Graft Data at American Society for Peripheral Nerve & American Society for Reconstructive Microsurgery 2013 Meetings
3. AxoGen, Inc. Announces Presentation of Avance® Nerve Graft Data at American Association for Hand Surgery 2013 Annual Meeting
4. AxoGen, Inc. to sponsor Educational Symposium and Panel Discussion at 2013 Annual Meetings of American Association for Hand Surgery, American Society for Peripheral Nerve, and American Society for Reconstructive Microsurgery
5. TGen findings highlighted at 7th annual cancer conference
6. Highlights on women, minorities and persons with disabilities in science and engineering
7. Eldon James Highlights Eco-Friendly Tubing and Fitting Assemblies at MedTec Europe
8. New IOM report highlights PEPFARs successes
9. Enhanced Microsoft SharePoint 2013 and Microsoft Office 365 Support Highlights Release of AvePoint’s DocAve 6 Service Pack 2
10. Research from the 2013 Genitourinary Cancers Symposium highlights new insights on high-risk prostate cancer prevalence and treatment, compares benefit of surveillance and surgery for management of small kidney tumors
11. Mileage Ads Highlights Publishers Can Earn More At
Post Your Comments:
(Date:11/30/2015)... ... November 30, 2015 , ... Until now, the St. Louis ... the MOMS (Management of Myelomeningocele Study) trial. One of these exclusion criteria was a ... BMI of 18.5 to 24.9 is considered normal, 25 - 29.9 is overweight and ...
(Date:11/30/2015)... ... November 30, 2015 , ... ... . The directory is specialized and only includes chiropractic clinics in the US. ... competent and trustworthy alternative health practitioner when back pain sets in. When people ...
(Date:11/30/2015)... Creek, Michigan (PRWEB) , ... November 30, 2015 , ... ... MI, the American Cancer Society held an annual fundraising event, a 5K walk known ... a holistic treatment center for substance abuse which is also located in Battle Creek, ...
(Date:11/30/2015)... ... November 30, 2015 , ... ... a University of Delaware Accounting and Management of Information Systems course. Based in ... mid-market businesses. Sommer will speak at before student in the Enterprise Resource Planning ...
(Date:11/30/2015)... Baltimore, MD (PRWEB) , ... November 30, 2015 , ... ... has teamed up with Public Television’s Travel With Kids to promote ... follows the Simmons family as they explore international destinations and educate families about the ...
Breaking Medicine News(10 mins):
(Date:11/30/2015)... , Nov. 30, 2015  The ... norm in U.S. medical imaging is on ... popular accountable care payer-provider contracts are set ... in their wake, alter provider-vendor relationships. The ... will push forward new purchasing frameworks in ...
(Date:11/30/2015)... , Nov. 30, 2015 Cumberland Pharmaceuticals (CPIX), ... present live at on December 3, 2015. ... TIME: 3:15p.m. ET LINK: ... LINK: --> ... event where investors are invited to ask the company questions ...
(Date:11/30/2015)... Nov. 30, 2015 Varian Medical Systems (NYSE: VAR ... educational partnership with Apollo Hospitals Group, the largest hospital chain in ... help train radiation technologists in the country. The MoU was signed ... Knowledge, and Ashok Kakkar , Varian,s India ... India , Varian intends to deploy its Access ...
Breaking Medicine Technology: